Suppr超能文献

[融合基因表达质粒HBV preS2S-rhGM-CSF的构建与表达]

[Construction and expression of fusion gene expression plasmid HBV preS2S-rhGM-CSF].

作者信息

Guo Xiao-lan, Deng Jian-kang, Zhu Dao-yin, Tang En-jie

机构信息

Department of Clinical Laboratory, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China.

出版信息

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2004 Sep;20(5):548-51.

Abstract

AIM

To construct GM-CSF and preS2 fusion gene expression plasmid to enhance the immunogenicity of hepatitis B DNA vaccine.

METHODS

HBV preS2S gene(846 bp) and rhGM-CSF gene(384 bp) were amplified by PCR, respectively. The eukaryotic expression plasmid pcDNA3.1-S2S-rhGM-CSF was constructed by means of T-A clone and directional gene cloning techniques, and then the recombinant plasmid was expressed in HepG2 cells.

RESULTS

Restriction enzyme digestion analysis, PCR amplification and/or DNA sequencing proved that the recombinant plasmid was constructed successfully. The transcription of target gene was confirmed by RT-PCR. The fusion protein expressed in HepG2 cells could reacted to the monoclonal antibodies (mAbs) against HBsAg, preS2 and GM-CSF, respectively.

CONCLUSION

The successful construction and expression of pcDNA3.1-S2S-rhGM-CSF lay the foundation for further study of HBV DNA vaccine.

摘要

目的

构建GM-CSF与preS2融合基因表达质粒,以增强乙肝DNA疫苗的免疫原性。

方法

分别通过PCR扩增HBV preS2S基因(846 bp)和rhGM-CSF基因(384 bp)。利用T-A克隆和定向基因克隆技术构建真核表达质粒pcDNA3.1-S2S-rhGM-CSF,然后将重组质粒在HepG2细胞中表达。

结果

限制性内切酶消化分析、PCR扩增和/或DNA测序证明重组质粒构建成功。通过RT-PCR证实了靶基因的转录。在HepG2细胞中表达的融合蛋白可分别与抗HBsAg、preS2和GM-CSF的单克隆抗体发生反应。

结论

pcDNA3.1-S2S-rhGM-CSF的成功构建与表达为进一步研究乙肝DNA疫苗奠定了基础。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验